ERYTECH Pharma S.A. Gains 30.5%
Thu, Mar 23, 2023 at 07:23 PM
ERYTECH Pharma S.A. (ERYP:NASDAQ) shot up at $1.03, a gain of 30.5%. On Thu, Mar 23, 2023, ERYP:NASDAQ hit a New 2-Week High of $1.03. The stock got featured on our News Catalysts scanner on Wed, Mar 22, 2023 at 06:50 PM in the 'INVESTOR UPDATE' category. From Thu, Mar 09, 2023, the stock recorded 33.33% Up Days and 40.00% Green Days
About ERYTECH Pharma S.A. (ERYP:NASDAQ)
Erytech Pharma is a biopharmaceutical company. The Company's product ERY-ASP, named GRASPA 2 in Europe and Israel, is positioned in the treatment of acute leukemia, a cancer of the blood and bone marrow.
Top 10 Gainers:
- Boxed Inc. (BOXD:NYSE), 91.38%
- DiamondHead Holdings Corp. (DHHC:NASDAQ), 82.63%
- FiscalNote Holdings Inc. Class A (NOTE:NYSE), 75%
- Jaguar Health, Inc. (JAGX:NASDAQ), 39.51%
- Sentage Holdings Inc. (SNTG:NASDAQ), 39.43%
- Amprius Technologies Inc. (AMPX:NYSE), 39.09%
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 35.79%
- SQZ Biotechnologies Company (SQZ:NYSE), 32.65%
- ERYTECH Pharma S.A. (ERYP:NASDAQ), 30.5%
- BM Technologies Inc. (BMTX:NYSEMKT), 29.21%